Where to buy Upadacitinib

Upadacitinib (Upadacitinib) is a Janus kinase (JAK) inhibitor. JAKs are a group of intracellular enzymes involved in the signaling of inflammatory cytokines, such as interferons and interleukins. There are four subtypes of JAK (JAK1, JAK2, JAK3, and tyrosine kinase 2). Upadatinib is a selective JAK1 inhibitor and is a new drug for the treatment of moderate to severe rheumatoid arthritis (an autoimmune disease characterized by inflammation and bone destruction). In addition to rheumatoid arthritis, upadatinib is currently used to treat a variety of autoimmune diseases, including ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, Crohn's disease, active nonradiographic axial spondyloarthritis, and atopic dermatitis. However, upadatinib can sometimes cause side effects, including neutropenia, liver disease, venous thrombosis, and infection.

The original drug Upadatinib has been launched in China, and has subsequently entered the scope of Class B medical insurance. Reimbursement is limited to eligible patients. Specifications The price of 15mg*28 tablets per box may be around 3,000 yuan, and this drug may be sold in domestic hospitals or pharmacies. The European version of the original drug sold overseas is priced at more than 20,000 yuan for 15mg*30 tablets (the price may fluctuate due to exchange rates), which is expensive. Cheaper upadatinib generic drugs are also sold overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 15mg*30 tablets produced by Bangladesh pharmaceutical factory is around 900 yuan (the price may fluctuate due to the exchange rate). For specific drug prices and drug information, consult a Yaode medical consultant.